Semin Vasc Med 2005; 5(2): 98-109
DOI: 10.1055/s-2005-872396
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001 USA.

Genetic Determinants of Plasma Total Homocysteine

Henkjan Gellekink1 , Martin den Heijer2 , 3 , Sandra G. Heil1 , Henk J. Blom1
  • 1Laboratory of Pediatrics and Neurology (424), Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • 2Department of Endocrinology (531), Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • 3Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. Juli 2005 (online)

Zoom Image

ABSTRACT

Hyperhomocysteinemia (Hhcy) is an established risk factor for various pathologies including arterial vascular disease and venous thrombosis, congenital malformations and other pregnancy complications, and dementia. Homocysteine remethylation, transsulfuration, and export to the blood/extracellular compartment determine homocysteine concentrations. Any disturbance in these routes may lead to Hhcy and potentially increase risk of disease. In this report, we aim to review all known polymorphisms involved in homocysteine and B-vitamin metabolism that have been assessed for their effect on tHcy. In the last section, we summarize the polymorphisms, for which the obtained data provides evidence for their involvement in Hhcy at the population level, and discuss how to continue our search for genetic determinants of tHcy.